• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催乳素释放肽及其类似物对 SH-SY5Y 细胞的细胞信号转导和抗凋亡作用。

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.

机构信息

Institute of Organic Chemistry and Biochemistry, AS CR, Prague 16000, Czech Republic.

First Faculty of Medicine, Charles University, Prague 12108, Czech Republic.

出版信息

Int J Mol Sci. 2020 Sep 1;21(17):6343. doi: 10.3390/ijms21176343.

DOI:10.3390/ijms21176343
PMID:32882929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7503370/
Abstract

Prolactin-releasing peptide (PrRP), a natural ligand for the GPR10 receptor, is a neuropeptide with anorexigenic and antidiabetic properties. Due to its role in the regulation of food intake, PrRP is a potential drug for obesity treatment and associated type 2 diabetes mellitus (T2DM). Recently, the neuroprotective effects of lipidized PrRP analogs have been proven. In this study, we focused on the molecular mechanisms of action of natural PrRP31 and its lipidized analog palm-PrRP31 in the human neuroblastoma cell line SH-SY5Y to describe their cellular signaling and possible anti-apoptotic properties. PrRP31 significantly upregulated the phosphoinositide-3 kinase-protein kinase B/Akt (PI3K-PKB/Akt) and extracellular signal-regulated kinase/cAMP response element-binding protein (ERK-CREB) signaling pathways that promote metabolic cell survival and growth. In addition, we proved via protein kinase inhibitors that activation of signaling pathways is mediated specifically by PrRP31 and its palmitoylated analog. Furthermore, the potential neuroprotective properties were studied through activation of anti-apoptotic pathways of PrRP31 and palm-PrRP31 using the SH-SY5Y cell line and rat primary neuronal culture stressed with toxic methylglyoxal (MG). The results indicate increased viability of the cells treated with PrRP and palm-PrRP31 and a reduced degree of apoptosis induced by MG, suggesting their potential use in the treatment of neurological disorders.

摘要

促泌乳素释放肽(PrRP)是 GPR10 受体的天然配体,是一种具有厌食和抗糖尿病特性的神经肽。由于其在调节食物摄入中的作用,PrRP 是肥胖症治疗和相关 2 型糖尿病(T2DM)的潜在药物。最近,已经证明了脂质化 PrRP 类似物的神经保护作用。在这项研究中,我们专注于天然 PrRP31 及其棕榈酸化类似物 palm-PrRP31 在人神经母细胞瘤细胞系 SH-SY5Y 中的作用机制,以描述其细胞信号转导和可能的抗凋亡特性。PrRP31 显著上调了磷酸肌醇-3 激酶-蛋白激酶 B/Akt(PI3K-PKB/Akt)和细胞外信号调节激酶/cAMP 反应元件结合蛋白(ERK-CREB)信号通路,促进代谢细胞存活和生长。此外,我们通过蛋白激酶抑制剂证明,信号通路的激活是由 PrRP31 及其棕榈酸化类似物特异性介导的。此外,通过使用 SH-SY5Y 细胞系和用毒性甲基乙二醛(MG)处理的大鼠原代神经元培养物激活 PrRP31 和 palm-PrRP31 的抗凋亡途径,研究了其潜在的神经保护特性。结果表明,用 PrRP 和 palm-PrRP31 处理的细胞活力增加,MG 诱导的细胞凋亡程度降低,表明它们在治疗神经紊乱方面具有潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/290af06fc657/ijms-21-06343-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/46bc64b99a7b/ijms-21-06343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/37e1bb563423/ijms-21-06343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/f9b62b9f521d/ijms-21-06343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/728ac34dec6e/ijms-21-06343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/7c5d3bb822b3/ijms-21-06343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/fdcc1bad9460/ijms-21-06343-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/20e110f72010/ijms-21-06343-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/48de6f68d6e0/ijms-21-06343-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/7360f1fb7ed4/ijms-21-06343-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/290af06fc657/ijms-21-06343-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/46bc64b99a7b/ijms-21-06343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/37e1bb563423/ijms-21-06343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/f9b62b9f521d/ijms-21-06343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/728ac34dec6e/ijms-21-06343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/7c5d3bb822b3/ijms-21-06343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/fdcc1bad9460/ijms-21-06343-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/20e110f72010/ijms-21-06343-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/48de6f68d6e0/ijms-21-06343-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/7360f1fb7ed4/ijms-21-06343-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c67/7503370/290af06fc657/ijms-21-06343-g010.jpg

相似文献

1
Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.催乳素释放肽及其类似物对 SH-SY5Y 细胞的细胞信号转导和抗凋亡作用。
Int J Mol Sci. 2020 Sep 1;21(17):6343. doi: 10.3390/ijms21176343.
2
Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study.棕榈酰化促泌乳素释放肽增加了与 GPR10、NPFF-R2 和 NPFF-R1 受体的亲和力和激活作用:体外研究。
Int J Mol Sci. 2021 Aug 18;22(16):8904. doi: 10.3390/ijms22168904.
3
Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.具有修饰C末端芳香环的催乳素释放肽脂质化类似物的药理学特性
J Physiol Pharmacol. 2016 Feb;67(1):121-8.
4
Prolactin-releasing peptide: a new tool for obesity treatment.催乳素释放肽:一种治疗肥胖症的新工具。
J Endocrinol. 2016 Aug;230(2):R51-8. doi: 10.1530/JOE-16-0046.
5
Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.新型催乳素释放肽脂质化类似物具有延长的半衰期,在外周给药后发挥抗肥胖作用。
Int J Obes (Lond). 2015 Jun;39(6):986-93. doi: 10.1038/ijo.2015.28. Epub 2015 Mar 16.
6
Characterization of prolactin-releasing peptide: binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor.催乳素释放肽的特性:在表达其受体的啮齿动物垂体细胞系中的结合、信号转导和激素分泌。
Peptides. 2011 Apr;32(4):811-7. doi: 10.1016/j.peptides.2010.12.011. Epub 2010 Dec 23.
7
Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.瘦素和脂质化 PrRP 对 ob/ob 小鼠代谢途径的协同作用。
J Mol Endocrinol. 2020 Feb;64(2):77-90. doi: 10.1530/JME-19-0188.
8
Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.脂质化促泌乳素释放肽激动剂可减轻神经元低温诱导的 tau 过度磷酸化。
J Alzheimers Dis. 2019;67(4):1187-1200. doi: 10.3233/JAD-180837.
9
Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice.对NMRI雄性小鼠外周给予棕榈酰化催乳素释放肽可诱导参与能量稳态的下丘脑神经元中Fos表达。
Brain Res. 2015 Nov 2;1625:151-8. doi: 10.1016/j.brainres.2015.08.042. Epub 2015 Sep 8.
10
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.利拉鲁肽和一种促泌乳素释放肽的脂质化类似物在β-淀粉样蛋白病理的小鼠模型中显示出神经保护作用。
Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11.

引用本文的文献

1
Peptidergic Systems and Neuroblastoma.肽能系统与神经母细胞瘤
Int J Mol Sci. 2025 Apr 8;26(8):3464. doi: 10.3390/ijms26083464.
2
Liquid Biopsy in Alzheimer's Disease Patients Reveals Epigenetic Changes in the Gene.阿尔茨海默病患者的液体活检揭示了 基因中的表观遗传变化。
Cells. 2023 Nov 22;12(23):2679. doi: 10.3390/cells12232679.
3
Potential Mechanisms of Biejiajian Pill in the Treatment of Diabetic Atherosclerosis Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.基于网络药理学、分子对接和分子动力学模拟探讨鳖甲煎丸治疗糖尿病动脉粥样硬化的潜在机制

本文引用的文献

1
Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.PI3K/AKT/mTOR信号通路在神经退行性疾病和肿瘤中的作用。
Cell Biosci. 2020 Apr 1;10(1):54. doi: 10.1186/s13578-020-00416-0. eCollection 2020.
2
Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.瘦素和脂质化 PrRP 对 ob/ob 小鼠代谢途径的协同作用。
J Mol Endocrinol. 2020 Feb;64(2):77-90. doi: 10.1530/JME-19-0188.
3
Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.泌乳素释放肽:生理和药理学特性。
Evid Based Complement Alternat Med. 2022 Aug 12;2022:3296279. doi: 10.1155/2022/3296279. eCollection 2022.
4
Prolactin-Releasing Peptide Differentially Regulates Gene Transcriptomic Profiles in Mouse Bone Marrow-Derived Macrophages.催乳素释放肽对小鼠骨髓来源巨噬细胞的基因转录组图谱具有差异性调控作用。
Int J Mol Sci. 2021 Apr 24;22(9):4456. doi: 10.3390/ijms22094456.
Int J Mol Sci. 2019 Oct 24;20(21):5297. doi: 10.3390/ijms20215297.
4
Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.脂质化促泌乳素释放肽激动剂可减轻神经元低温诱导的 tau 过度磷酸化。
J Alzheimers Dis. 2019;67(4):1187-1200. doi: 10.3233/JAD-180837.
5
Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer.甲基乙二醛是一种强效的 AGEs 诱导剂,它将糖尿病和癌症联系在一起。
Diabetes Res Clin Pract. 2019 Feb;148:200-211. doi: 10.1016/j.diabres.2019.01.002. Epub 2019 Jan 18.
6
The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.厌食肽在阿尔茨海默病病理实验模型中的作用。
J Endocrinol. 2019 Feb 1;240(2):R47-R72. doi: 10.1530/JOE-18-0532.
7
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.利拉鲁肽和一种促泌乳素释放肽的脂质化类似物在β-淀粉样蛋白病理的小鼠模型中显示出神经保护作用。
Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11.
8
Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.新型泌乳素释放肽类似物改善tau 病小鼠模型的记忆障碍并减轻 Tau 蛋白过度磷酸化
J Alzheimers Dis. 2018;62(4):1725-1736. doi: 10.3233/JAD-171041.
9
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.脂质化促泌乳素释放肽改善代谢综合征的葡萄糖耐量:科列茨基和自发性高血压大鼠研究。
Nutr Diabetes. 2018 Jan 16;8(1):5. doi: 10.1038/s41387-017-0015-8.
10
Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.胃饥饿素长效稳定类似物的潜在神经保护和抗凋亡特性:一项使用SH-SY5Y细胞的体外研究
Physiol Res. 2018 May 4;67(2):339-346. doi: 10.33549/physiolres.933761. Epub 2018 Jan 5.